









Markets
/
Stocks
/
nasdaq-sbfm
/

Sunshine Biopharma Inc

SBFM

View Detailed Chart

1.410USD

-0.020-1.39%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

3.82MMarket Cap

LossP/E TTM



Sunshine Biopharma Inc

1.410

-0.020-1.39%

Overview Company Financials

Financials

Intraday

30m

Today

-1.39%

5 Days

-10.19%

1 Month

-9.03%

6 Months

-46.79%

Year to Date

-53.00%

1 Year

-69.86%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 1 analysts

BUY

Current Rating

7.000

Target Price

396.45%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

Sunshine Biopharma Inc

SBFM

Biogen Inc

BIIB

Vertex Pharmaceuticals Inc

VRTX

Alnylam Pharmaceuticals Inc

ALNY

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(9)

Neutral(2)

Buy(0)

Indicators

Sell(3)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.035

Neutral

RSI(14)

39.645

Neutral

STOCH(KDJ)(9,3,3)

21.255

Sell

ATR(14)

0.081

Low Volatility

CCI(14)

-203.657

Oversold

Williams %R

77.239

Sell

TRIX(12,20)

0.010

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

1.470

Sell

MA10

1.520

Sell

MA20

1.528

Sell

MA50

1.510

Sell

MA100

1.571

Sell

MA200

2.159

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Sunshine Biopharma, Inc. is a Canada-based pharmaceutical company. The Company offers and researches life-saving medicines in a variety of therapeutic areas, including oncology and antivirals. The Company has over 32 additional generic prescription drugs. In addition, the Company is conducting a proprietary drug development program which consists of K1.1 mRNA, an mRNA-Lipid Nanoparticle targeted for liver cancer, and PLpro protease inhibitor, a small molecule for treatment of SARS Coronavirus infections. The Company operates through two segments: Prescription Generic Pharmaceuticals (Generic Pharmaceuticals) and Nonprescription Over-The-Counter Products (OTC Products). It also operates two wholly owned subsidiaries: NoraPharma Inc., which has a portfolio of pharmaceutical products consisting of approximately 61 generic prescription drugs on the market in Canada, and Sunshine Biopharma Canada Inc., which develops and sells non-prescription over-the-counter (OTC) products.

Ticker SymbolSBFM

CompanySunshine Biopharma Inc

CEODr. Steve N. Slilaty

Websitehttps://www.sunshinebiopharma.com/